X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.biopharmadive.com/news/spectrum-fda-rejection-poziotinib-layoffs/637358/#:~:text=Spectrum%20Pharmaceuticals%20will%20lay%20off,immediately%E2%80%9D%20discontinue%20investment%20into%20poziotinib.
https://endpts.com/spectrum-implodes-after-a-harsh-public-slapdown-and-now-a-crl-from-richard-pazdur/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-raises-concerns-spectrum-pharmas-cancer-drug-2022-09-20/
http://www.koreabiomed.com/news/articleView.html?idxno=14405
http://www.koreabiomed.com/news/articleView.html?idxno=12538
https://www.businesswire.com/news/home/20210918005006/en/Spectrum-Pharmaceuticals-Presents-Late-Breaker-Oral-Presentation-of-Poziotinib-Data-in-First-Line-NSCLC-Patients-with-HER2-Exon-20-Insertion-Mutations-at-ESMO-Congress-2021
https://www.evaluate.com/vantage/articles/news/snippets/esmo-2021-poziotinib-could-add-first-line-string-its-bow
https://www.businesswire.com/news/home/20210528005031/en/Spectrum-Pharmaceuticals-to-Present-Data-for-Poziotinib-in-Patients-with-Brain-Metastases-at-the-Upcoming-2021-ASCO-Annual-Meeting
https://www.onclive.com/view/fda-grants-fast-track-status-to-poziotinib-for-her2-exon-20-mutated-nsclc
https://www.biospace.com/article/releases/spectrum-pharmaceuticals-presents-results-in-her2-exon-20-insertion-mutations-from-cohort-2-of-the-poziotinib-zenith20-clinical-trial/
https://www.businesswire.com/news/home/20200727005679/en/Spectrum-Pharmaceuticals-Announces-Positive-Topline-Results-HER2
https://www.businesswire.com/news/home/20200428005286/en/Spectrum-Pharmaceuticals-Strategy-Update-Poziotinib-Development-Program
https://seekingalpha.com/news/3503957-spectrum-pharma-announces-publication-positive-poziotinib-data-cancer-cell
https://medcitynews.com/2019/01/spectrum-pharmaceuticals-sells-marketed-drugs-to-aurobindo-subsidiary-for-up-to-300m/?rf=1
https://endpts.com/thats-gotta-hurt-fda-turns-thumbs-down-on-spectrums-breakthrough-pitch-for-cancer-drug-poziotinib-and-shares-tumble/
http://investor.sppirx.com/news-releases/news-release-details/spectrum-pharmaceuticals-announces-update-md-andersons-phase-2
https://seekingalpha.com/article/4096540-expect-spectrum-pharmaceuticals-robust-earnings
Market Place
Share 
